HealthEdge Investment Partners, LLC, a Tampa, Florida-based private equity firm focused on the healthcare industry, held the first closing of its third fund, at over $100m.
HealthEdge Investment Fund III, L.P., which received backing from both existing and two new institutional investors, has a final target of $175m to be reached within the end of 2016.
Led by Managing Partners Brian Anderson and Phillip Dingle, HealthEdge focuses on investing in U.S.-based lower middle market healthcare businesses. It acquires control or significant minority ownership positions in companies with enterprise values between $10m and $100m targeting niche segments including specialty medical products, healthcare services, healthcare information technology, and specialty distribution.
Portfolio companies include Medicine-On-Time, Medical Neurogenetics, Santus, DataDimensions, Advantage Medical Cables, The Corridor Group, Enaltus, Woodbury Health Products, Infinity Homecare, Life Sync, Advanced Bio-Technologies, etc.
The firm’s team also includes Partner Jeffery Thompson, Associate Charles Davis, and Principal Scott Heberlein.